The AlphaLISA Human IFN-γ Detection Kit is designed for the quantitative determination of human IFN-γ in serum, buffered solution or cell culture medium using a homogeneous (no wash steps, no separation steps) assay.
Please enter valid quantity
Please login to add favorites
NULL OR EMPTY CART
|Product Number||Unit Size||List Price||Your Price||Quantity|
|AL217C||500 assay points||1476.00 USD|
|AL217F||5,000 assay points||9800.00 USD|
You successfully added item(s) to your cart
Interferons (IFNs) activity has been discovered due to their antiviral effects. In humans, there are three families of IFNs: IFN type I (IFN-a, ß, ?, e, and ?), IFN type II (one single representative, IFN-?), and IFN type III (IFN-?1-3). Antigens and mitogens stimulate in Natural Killer (NK) and activated helper T lymphocytes (Th1) the production of IFN-?. Human IFN-? is a 140 amino acids polypeptide that shows multiple effects; it induces the production of cytokines, upregulates the expression of class I and II MHC antigens, and leukocyte adhesion molecules. It also activates macrophages, enhances the secretion of immunoglobulins by B cells, and potentiates Th1 cell expansion. Response to IFN-? is mediated by the hetetodimeric IFN-? Receptor, triggering a signalling cascade involving JAK1, JAK2, and STAT1. Importantly, IFNs have been proved to be effective in the treatment of several viral infections and cancers.
AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
Disclaimer: For research use only. Not for use in diagnostic procedures.
|Assay Target Class||Cytokine|
|Experimental Type||In vitro|
|Product Brand Name||AlphaLISA|
|Shipping Condition||Blue Ice|
|Unit Size||5,000 assay points|
You have selected:
|Resource Type||File Name||File Format|
|Application Note||A Comparison of AlphaLISA and TR-FRET Homogeneous Immunoassays in Serum-Containing Samples||PDF 1 MB|
|Application Note||AlphaLISA Automation - Use of the JANUS Automated Workstation to automate AlphaLISA assays||PDF 870 KB|
|Application Note||Evaluating a TNF-alpha immunoassay using EnSpire AlphaPLUS ELISA and AlphaLISA technologies||PDF 185 KB|
|Technical Note||HiBlock Buffer Technical Data Sheet||PDF 333 KB|
|Data Sheet||Manual AlphaLISA Human IFN? AL217||PDF 288 KB|
|Poster||A Comparison of AlphaLISABead-Based Luminescence and Electrochemiluminescence Immunoassay Technologies for Detection of Human EPO, Amyloid Beta 42 and VEGF in Complex Sample Matrices||PDF 179 KB|
|Poster||A Comparison of a Homogeneous Bead-Based Amplified Luminescence Technology AlphaLISA and a Colorimetric ELISA for Detection of Human Matrix Metalloproteinase 9 in Complex Sample Matrices||PDF 1 MB|
|Poster||All-In-One-Well AlphaLISA Assays for Direct Biomarker Quantification in Cell Cultures||PDF 288 KB|
|Poster||AlphaLISA Assays are Homogeneous Sensitive Immunoassays for Detection of Analytesin a Variety of Biological Matrices||PDF 273 KB|
|Poster||Development of New AlphaLISA No-wash Immunoassay Kits for Sensitive, Rapid and Efficient Quantification of Cytokines||PDF 279 KB|
|Event||Society of Laboratory Automation & Screening (SLAS)||Event|